ELISA and RT-qPCR evaluation of cytokines in the embryonic mouse brain. by Adrienne J. Bradley (20861948)

Subjects:

Mean concentrations of sum sesquiterpenes and single sesquiterpenes: β-caryophyllene, α-humulene, δ-selinene, γ-cadinene, δ-cadinene, nerolidol, maaliol, germacrene D-4-ol, spathul... by Valtcho D. Zheljazkov (627617)

MTT experiment shows that the seven MUT plasmids of NANOG protein can significantly inhibit the proliferation of colon cancer stem cells. by Yin Tian (181303)

The theme, top terms, and description of five topic groups. by Yuqi Zhang (286958)

Subjects:

Volume distribution and sentiment of positive, negative, and neutral tweets. by Yuqi Zhang (286958)

Subjects:

Monthly volume distribution and sentiment score of five topic groups. by Yuqi Zhang (286958)

Subjects:

Top 10 words and their associated weights for the 10 topics prior to manual grouping. by Yuqi Zhang (286958)

Subjects:

The sentiment score and number of tweets per month from 09/01/2018 to 01/31/2020. by Yuqi Zhang (286958)

Subjects:

Examples of positive, negative, and neutral tweets. Each tweet is assigned to only one of the categories based on its sentiment score calculated by VADER. by Yuqi Zhang (286958)

Subjects:

Characteristics of patients at risk of pneumococcal disease in France in 2020 and vaccination rates. by Benjamin Wyplosz (22032756)

Subjects:

Comparative cost analysis of HCVST and PL-HCVT models (in US$). by Bao Vu Ngoc (14551955)

Subjects:

Characteristics associated with pneumococcal primary vaccination (A) and 2020−21 seasonal influenza vaccination (B) in patients with immunodepression in France in 2020 (multivariab... by Benjamin Wyplosz (22032756)

Subjects:

Characteristics of propensity score matched groups. by Clemens Plattner (21567706)

Subjects:

Pneumococcal (black bars) and influenza (white bars) vaccine coverage in patients living with comorbidities (A), and immunosuppressive conditions (B), who are at risk of pneumococc... by Benjamin Wyplosz (22032756)

Subjects:

Study population: patients living with comorbidities (on the left) and immunosuppressive conditions (on the right) who are at risk of pneumococcal disease in France in the year 202... by Benjamin Wyplosz (22032756)

Subjects:

Characteristics associated with pneumococcal primary vaccination (A) and 2020−21 seasonal influenza vaccination (B) in patients with comorbidities in France in 2020 (multivariable... by Benjamin Wyplosz (22032756)

Subjects:

Characteristics of propensity score matched groups. by Clemens Plattner (21567706)

Subjects:

Pneumococcal (black bars) and influenza (white bars) vaccine coverage in patients living with comorbidities (A), and immunosuppressive conditions (B) according to age of 65 years,... by Benjamin Wyplosz (22032756)

Subjects:

Insulin-free survival in patients with and without FHD. by Clemens Plattner (21567706)

Subjects:

Event-free survival analysis of microvascular outcome. by Clemens Plattner (21567706)

Subjects: